Consistently, treatment with the NFAT inhibitory peptide VIVIT almost completely abolished SKAP1‐induced CXCL8 expression (Figure 6E), suggesting that SKAP1 dependents on NFATc1 to increase CXCL8 expression in colon cancer cells. Here, SKAP1 is linked to malignant colon neoplasm.